One Alewife CenterCambridge, MA 02140
David de Graaf
President and CEO
Selventa is pioneering the development of Systems Diagnostics (SysDx™). This novel approach to diagnostic development harnesses a comprehensive range of complex, biological information (genomic, epigenomic, transcriptomic, proteomic, metabolomic, electronic medical records) to generate a clinically relevant dashboard that physicians, patients and researchers can use to make an optimal treatment decision or stratify patient populations.
Jim Matheson is Chairman of the Board and Harry Wilcox is on the Board of Directors.